Richard A. Miller M.D., President and CEO at Corvus Pharmaceuticals, Inc. (CRVS), bought 20,000 shares at $0.82 ($16K) on 2022-09-20, disclosed to the SEC on 2022-09-20.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $0.81 | 12,300 | $10K | 61.2% |
| 2 | $0.82 | 2,700 | $2K | 13.6% |
| 3 | $0.82 | 5,000 | $4K | 25.2% |
| Total | $0.81 avg | 20,000 | $16K | 100% |
| Filing → |
| CRVS | BUY | 2022-12-15 | $45K | — | Filing → |
| CRVS | BUY | 2022-09-28 | $19K | — | Filing → |
| CRVS | BUY | 2022-06-28 | $10K | — | Filing → |